COVID IS SO OVER: ‘Humiliating’: Pfizer cancels COVID vaccine trial for lack of interest as global scrutiny mounts.

Five years after their wide deployment, first on a voluntary basis, then under threat of firing for nearly 100 million Americans at the direction of the White House, COVID-19 vaccines for at least low-risk groups may be on the way out amid higher regulatory requirements and indifference to the jabs by the vast majority of Americans.

Pfizer and its COVID mRNA vaccine partner BioNTech abruptly pulled the plug on their trial for healthy 50-64 year-olds, telling trial investigators in a March 30 letter they were coming up short on the 25,000-30,000 enrollment needed to generate enough data to evaluate the jabs, Reuters reported, citing a letter it viewed.

Friday was the last day that Pfizer was scheduled to monitor trial participants for signs of COVID illness, the letter reportedly said. “Two sources from companies” that manage 9% of trial sites told the wire service that Pfizer told them in writing weeks earlier to stop recruitment.

“This study is not ending as a result of any safety or benefit-risk concerns,” Pfizer and BioNTech told the wire service, citing their “inability to generate relevant post-marketing data” with lagging enrollment.

And yet there are still people wearing cloth masks.